Cross-referencing clinical data
EarlyHydroxypropyl Beta Cyclodextrin (HPBCD)
Hydroxypropyl Beta Cyclodextrin (HPBCD).
A molecular cage that wraps around poorly-absorbed ingredients to dramatically improve their bioavailability. Wraps around poorly-soluble ingredients to dramatically improve their absorption. Think of it as a molecular delivery vehicle.
EarlyResearch strength
Reviewed March 2026
What Hydroxypropyl Beta Cyclodextrin (HPBCD) is, and what it does.
- Does it work
- As an excipient, it's actually one of the best. It doesn't have standalone benefits, but it genuinely makes other ingredients work better.
- How much to take
- Not applicable on its own. The product determines the ratio.
- The first dose
- You won't feel HPBCD, but the active ingredient may kick in faster or stronger.
- With regular use
- No effects from HPBCD itself. Improved absorption of the main ingredient is the long-term benefit.
- How well tolerated
- FDA-approved for oral and injectable use. Very well-studied safety profile.
- How it feels
- You feel the main ingredient, not this.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Improves CoQ10 absorption 4-8x
- Enhances curcumin absorption
- Well tolerated in human use
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Questions people ask about Hydroxypropyl Beta Cyclodextrin (HPBCD).
- Does HPBCD actually improve absorption?
- Yes. This is well-proven for CoQ10 (4-8x improvement), curcumin, resveratrol, and several other poorly-soluble ingredients.
- How does it work?
- It's a ring-shaped molecule with a hollow center. Poorly-soluble ingredients fit inside the ring, which makes them dissolve in water much better. Better dissolution means better absorption.
- Is it safe?
- Very. The FDA has approved it for use in injectable drugs, which have the highest safety bar. Oral supplement use is well within safe limits.
- Does it work for all supplements?
- Only for ingredients that are poorly water-soluble. It's most valuable for CoQ10, curcumin, resveratrol, quercetin, and vitamin D.
- Is HPBCD the same as maltodextrin?
- No. Both come from starch, but cyclodextrins have a specific ring structure that traps molecules. Maltodextrin is just a broken-down starch with no encapsulation ability.
- Is Febreze really the same chemistry?
- Same concept. Febreze uses cyclodextrins to trap odor molecules inside the ring. Your supplement uses them to trap active ingredients for better delivery. Different scale, same trick.
Nothing to show here, and the reason why.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Hydroxypropyl Beta Cyclodextrin (HPBCD) has none that clears that bar.
No pairing for Hydroxypropyl Beta Cyclodextrin (HPBCD) has cleared review yet.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
Plays well withEstablished knowledge, not a trial
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Coenzyme Q10Established pharmacology of cyclodextrin inclusion complexes with lipophilic molecules
Coenzyme Q10 is a large, highly lipophilic quinone with poor dissolution in gut fluid, which is the step that limits how much of an oral dose ever reaches the enterocyte. Hydroxypropyl beta cyclodextrin carries a hydrophobic internal cavity and a hydrophilic outer shell, so it holds the quinone ring in solution as a guest molecule. The mechanism at work is dissolution, not any change to CoQ10 itself. The complex dissociates on dilution and the free molecule is what is absorbed.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Curcumin TurmericEstablished solubilisation chemistry for a poorly water-soluble polyphenol
Curcuminoids are close to insoluble in water and degrade at intestinal pH, which is why plain powder shows low systemic appearance. Inclusion in the cyclodextrin cavity keeps the diketone in solution and shields part of the molecule from hydrolysis. This is a formulation effect on delivery rather than a change in what curcumin does once absorbed.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Vitamin D3Established pharmacology: cyclodextrin complexation of fat-soluble vitamins
Cholecalciferol normally needs dietary fat and bile for micellar uptake. Complexed with hydroxypropyl beta cyclodextrin it disperses in aqueous media without an oil phase, which is why water-dispersible vitamin D powders and drops use it. The relevance is to products taken without food rather than to the vitamin's own actions.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Vitamin EEstablished formulation chemistry for tocopherol esters
Tocopherol and tocopheryl acetate are oils that will not stay dispersed in a clear aqueous drink. Cyclodextrin complexation gives a free-flowing powder that redisperses, which is the usual reason a beverage or effervescent format can carry vitamin E at all. Nothing about the vitamin's redox chemistry changes.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + AstaxanthinEstablished solubilisation of carotenoids by cyclodextrins
Astaxanthin is a long conjugated carotenoid that is both poorly soluble and prone to oxidation at its polyene chain. The cyclodextrin cavity holds the ionone end groups and reduces contact with oxygen and light. The practical effect is on dispersion and shelf stability in a formulation.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + QuercetinEstablished host-guest complexation of flavonoids
Quercetin aglycone dissolves poorly in intestinal fluid, so the amount available for uptake is dissolution-limited. Hydroxypropyl beta cyclodextrin forms a soluble inclusion complex with the B ring, keeping more of the dose in solution during transit. This addresses delivery only.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + ResveratrolEstablished complexation chemistry with stilbenes
Trans-resveratrol is sparingly water-soluble and isomerises under light. Encapsulation in the cyclodextrin cavity improves aqueous dispersion and slows photoisomerisation in the finished product. The stilbene still faces the same extensive first-pass conjugation once absorbed, so this is a formulation step and not a bioavailability guarantee.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + LuteinEstablished carotenoid solubilisation
Lutein is a xanthophyll normally delivered in an oil or a beadlet. Cyclodextrin complexation produces a water-dispersible powder suitable for tablets and drink mixes. Trade-off: the carrier adds considerable mass per milligram of carotenoid.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Vitamin AEstablished pharmacology of retinoid stabilisation in cyclodextrin
Retinol and retinyl esters oxidise readily and are oil-phase molecules. The cyclodextrin cavity limits oxygen and light exposure at the polyene chain and allows an aqueous format. This is stabilisation and dispersion, distinct from any effect on vitamin A status.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Vitamin K2 MK7Established solubilisation of a long-chain menaquinone
MK-7 carries a seven-isoprene tail that makes it strongly lipophilic and dependent on a fat vehicle. Complexation gives a dry, water-dispersible form used in tablets and gummies. The naphthoquinone head is also partly shielded from light.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + MCT OilEstablished formulation practice: two different vehicles for the same problem
Medium-chain triglyceride oil and cyclodextrin solve lipophilic delivery in opposite ways, one by providing a lipid phase and the other by providing a water-soluble host. In a single formula they compete for the same guest molecule, since a compound partitioned into the oil is not in the cavity. Products generally pick one route rather than layering both.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Black Pepper Extract BioperineEstablished pharmacology: two distinct routes to systemic exposure
Piperine acts after absorption by slowing glucuronidation of several polyphenols, while cyclodextrin acts before absorption by keeping the compound dissolved. The two operate at different steps, so a formula can use both without either substituting for the other. Neither addresses the parent compound's intrinsic clearance beyond those steps.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + BerberineEstablished solubilisation of a poorly soluble alkaloid
Berberine is an isoquinoline alkaloid with low aqueous solubility and heavy efflux at the intestinal wall. Cyclodextrin complexation addresses the solubility half of that problem only. Efflux transport remains the larger constraint, so the pairing is partial by design.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + Sunflower LecithinEstablished formulation chemistry of phospholipid versus cyclodextrin carriers
Lecithin delivers a lipophilic compound inside a phospholipid vesicle or micelle; cyclodextrin delivers it inside a sugar torus. Cyclodextrins also extract phospholipids and cholesterol from membranes and from liposomes, so a high cyclodextrin load can destabilise a lecithin-based carrier in the same product. Formulators usually separate the two phases.
Hydroxypropyl Beta Cyclodextrin (HPBCD) + PterostilbeneEstablished host-guest chemistry with dimethoxy stilbenes
Pterostilbene is more lipophilic than resveratrol because of its two methoxy groups, so it dissolves poorly in water while absorbing well once dissolved. The cyclodextrin cavity accommodates the stilbene core and holds it in aqueous solution. The step addressed is dissolution.
Who should be cautious
Talk to a doctor before taking Hydroxypropyl Beta Cyclodextrin (HPBCD) if any of these apply to you: Not absorbed itself (passes through), More expensive than standard excipients, FDA-approved for oral use. These are flags to check first, not effects Hydroxypropyl Beta Cyclodextrin (HPBCD) is known to cause.
Not medical advice. Show the label to your pharmacist.Getting Hydroxypropyl Beta Cyclodextrin (HPBCD) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
Not found in food
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Hydroxypropyl beta cyclodextrin (HPBCD)Beta-cyclodextrin with hydroxypropyl groups added at the 2, 3 and 6 hydroxyls, typically described by an average molar substitution near 0.6 to 0.9 per glucose unit.Fits Aqueous formats that need to carry a lipophilic active without an oil phase: drink mixes, effervescents, drops and some tablets.Trade-off Carrier mass is high relative to the active it holds, and the molar substitution grade changes solubility and complexation behaviour, so grades are not interchangeable in a validated formula.Formulation aid
Beta-cyclodextrinThe native seven-unit cyclic oligosaccharide with an intact intramolecular hydrogen-bond belt and no hydroxypropyl substitution.Fits Flavour masking and volatile retention in dry blends where high aqueous solubility is not required.Trade-off Far lower water solubility than the hydroxypropylated derivative, which limits how much guest it can carry in a liquid format.Formulation aid
What the strongest studies found
The essence, in one line each.
- The authors report that their CRE-Ter preparation increased osteogenic differentiation markers, reduced muscle cell atrophy markers and raised irisin expression in their model; hydroxypropyl beta cyclodextrin appears only as a named component and was not itself the tested variable.Animal study. Jantarawong et al., 2025 (PloS one). PMID 41343580 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Hydroxypropyl Beta Cyclodextrin (HPBCD). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
